Dr. Anusha Sunder*

Doctorate in Life Science/Human Nutrition, Accredited Certification in Nutrigenetics; Lead Scientist and Nutrigenetic Expert, Xcode Life Sciences, Pvt. Ltd. Chennai, India

*Corresponding Author: Dr. Anusha Sunder, Doctorate in Life Science/Human Nutrition, Accredited Certification in Nutrigenetics; Lead Scientist and Nutrigenetic Expert, Xcode Life Sciences, Pvt. Ltd. Chennai, India

Received: April 23, 2024; Published: June 04, 2024

Abstract

In India, cardiovascular diseases account for one in four deaths [1]. Alarmingly, young Indians are losing their lives to heart attack and cardiac arrest, age-wise a decade earlier compared to the western population. To quantify this statement, nearly 12 lakh youngsters have lost their lives to fatal heart events in 2022, says Dr.Manjinder Sandhu, cardiologist and angioplasty heart Surgeon at Gurgaon’s Artemis Hospital [2,3]. We loved to watch them on screen, but it was disheartening to bid adieu to such fitness freaks as Siddharth Shukla, Puneeth Rajkumar and Taraka Ratna when their heart beats’ silenced due to heart attack. Heart attack is striking younger and younger; be it the 23-year-old MTech student of IIT Kanpur, a 16-year old boy who collapsed while playing cricket, or a class 8 student of Rajkot, fatal heart events are mercilessly attacking the younger population. Considering the rising rates of cardiac events that are early-onset, sudden and fatal in our country, an immediate focus on timely diagnosis and appropriate management is of prime importance.

 Keywords: Cardiovascular Diseases; Heart Attack

References

1. Abdul-Aziz AA., et al. “Tackling the Burden of Cardiovascular Diseases in India”. Circulation: Cardiovascular Quality and Outcomes 4 (2019): e005195.
2. Iyengar SS., et al. “Premature coronary artery disease in India: coronary artery disease in the young (CADY) registry”. Indian Heart Journal2 (2017): 211-216.
3. 12 lakh Youngsters Die of Cardiac Arrest Every Year in India. Experts Explain How, Why. Last Updated: JANUARY 27, 19 (2022): 19.
4. Dhandapany PS., et al. “A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia”. Nature Genetics2 (2009): 187-191.
5. Maliye C., et al. “Relationship of anthropometric indicators with blood pressure levels in rural Wardha”. Indian Journal of Medical Research 5 (2006): 657-664.
6. Rapsomaniki E., et al. “Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people”. Lancet 9932 (2006): 1899-911.
7. Feingold KR. “Obesity and Dyslipidemia”. 2020 Nov 2. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Hofland J, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; (2020).
8. Howard BV., et al. “LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study”. Arteriosclerosis, Thrombosis, and Vascular Biology 3 (2000): 830-835.
9. Barrett-Connor E., et al. “Heart Disease and Diabetes”. In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3^rd Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); CHAPTER 18 (2018).
10. Khaw KT., et al. “Family history of heart attack: a modifiable risk factor?” Circulation2 (1986): 239-244.
11. Hoseini K., et al. “Family history of cardiovascular disease as a risk factor for coronary artery disease in adult offspring”. Monaldi Archives for Chest Disease 2 (2008): 84-87.
12. Butnariu LI., et al. “Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component?” Life (Basel)6 (2022): 865.
13. Sandhu RK., et al. “Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function”. Journal of the American College of Cardiology 9 (2022): 873-883.
14. Lee SR., et al. “Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation”. Frontiers in Cardiovascular Medicine 9 (2022): 885016.
15. Lopez VA., et al. “Coronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertension”. Journal of Clinical Hypertension (Greenwich) 9.6 (2007): 436-443.
16. Enas EA. “How to Beat the Heart Disease Epidemic among South Asians: A Prevention and Management Guide for Asian Indians and their Doctors”. Downers Grove: Advanced Heart Lipid Clinic (2005).
17. https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease/heart-health-screenings
18. Dariush Mozaffarian., et al. “Global Sodium Consumption and Death from Cardiovascular Causes”. The New England Journal of Medicine 371 (2014): 624-634.
19. , et al. “Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: A science advisory from the American Heart Association”. Circulation 129 (2014): 1173-1186.
20. , et al. “The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: A call to action from the American Heart Association”. Circulation 123.10 (2011): 1138-1143.
21. Kirsten Bibbins-Domingo., et al. “Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease". New England Journal of Medicine 362 (2010): 590-599.
22. Odegaard AO., et al. “Western-style fast food intake and cardiometabolic risk in an Eastern country”. Circulation 2 (2012): 182-188.
23. Tighe P., et al. “Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: a randomized controlled trial”. American Journal of Clinical Nutrition 92.4 (2010): 733-740.
24. Hollaender PL., et al. “Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies”. American Journal of Clinical Nutrition 3 (2015): 556-572.
25. Labonté MÈ., et al. “Adding MUFA to a dietary portfolio of cholesterol-lowering foods reduces apoAI fractional catabolic rate in subjects with dyslipidaemia”. British Journal of Nutrition 3 (2013): 426-436.
26. Berryman CE., et al. “Effects of almond consumption on the reduction of LDL-cholesterol: a discussion of potential mechanisms and future research directions”. Nutritional Review4 (2011): 171-185.
27. Banel DK and Hu FB. “Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review”. 90.1 (2009): 56-63.
28. Pan A., et al. “Meta-analysis of the effects of flaxseed interventions on blood lipids”. American Journal of Clinical Nutrition 2 (2009): 288-297.
29. Lankinen M., et al. “Effects of Whole Grain, Fish and Bilberries on Serum Metabolic Profile and Lipid Transfer Protein Activities: A Randomized Trial (Sysdimet)”. PLOS ONE (2014).
30. Karin Ried and Peter Fakler. “Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance”. Integr Blood Press Control 7 (2014): 71–82.
31. Yeh YY and Liu L. “Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies”. Journal of Nutrition3s (2001): 989S-93S.
32. He FJ., et al. “Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies”. Journal of Human Hypertension9 (2015): 717-28.
33. Luc Dauchet., et al. “Fruit and Vegetable Consumption and Risk of Coronary Heart Disease: A Meta-Analysis of Cohort Studies”. Journal of Nutrition10 (2006): 2588-2593.
34. Law MR and Morris JK. “By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease?” European Journal of Clinical Nutrition 52 (1998): 549-556.
35. Cornelis MC., et al. “Coffee, CYP1A2 genotype, and risk of myocardial infarction”. JAMA 10 (2006): 1135-1141.
36. Bond Brill J., et al. “Dose-response effect of walking exercise on weight loss. How much is enough?” International Journal of Obesity and Related Metabolic 11 (2002): 1484-1493.
37. Youssef MK. “The impact of obesity on walking and physical performance”. Egyptian Journal of Internal Medicine 26 (2014): 40–44.
38. Ruiz-Ramie JJ., et al. “Effects of exercise on HDL functionality”. Current Opinion in Lipidology 1 (2019): 16-23.
39. Balducci S., et al. “Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: A randomized controlled trial: The Italian Diabetes and Exercise Study”. Archives of Internal Medicine 170 (2010): 1794-1803.
40. Alanna Morris., et al. “Sleep Quality and Duration are Associated with Higher Levels of Inflammatory Biomarkers: the META-Health Study". Circulation 122 (2010).
41. Patel SR., et al. “Sleep duration and biomarkers of inflammation”. Sleep 32.2 (2009): 200-204.
42. Zhou Y., et al. “Sleep disorder, an independent risk associated with arterial stiffness in menopause”. Scientific Report1 (2017): 1904.
43. Choi Y., et al. “Sleep quality and arterial stiffness in middle-aged and older women”. Sleep Medicine1 (2013): e25.
44. S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 14.
45. Institute of Medicine. Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence. Washington, DC: The National Academies Press (2009).
46. Centers for Disease Control and Prevention. “Vital Signs: Disparities in Nonsmokers' Exposure to Secondhand Smoke — United States, 1999-2012”. Morbidity and Mortality Weekly Report4 (2015): 103-108.
47. Behbodikhah J., et al. “Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target”. Metabolites10 (2021): 690.
48. Ralph B D’Agostino., et al. “General Cardiovascular Risk Profile for Use in Primary Care. The Framingham Heart Study”. Circulation 117 (2008): 743-753.
49. Gerd Assmann., et al. “Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study”. Circulation 105 (2002): 310-315.

Citation

Citation: Dr. Anusha Sunder. “Early-onset heart attacks are rampant! How to curb?”.Acta Scientific Medical Sciences 8.7 (2024): 10-16.

Copyright

Copyright: © 2024 Dr. Anusha Sunder. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.